Full access
Clinical & Research News
Published Online: 21 September 2012

Data Point to Potential New Use for Common Antidepressant

Joan Arehart-TreichelAuthors Info & Affiliations
Publication: Psychiatric News
Volume 47, Number 18
https://doi.org/10.1176/pn.47.18.psychnews_47_18_15-b
Track CitationsAdd to favorites

Abstract

In addition to its usual psychiatric indications, the SSRI antidepressant fluoxetine may be useful for epilepsy patients who have learning difficulties.
The SSRI antidepressant fluoxetine may hold another benefit—helping people with mesial temporal lobe epilepsy who experience learning problems.
Many patients with mesial temporal lobe epilepsy complain of learning and memory problems. So William Gray, M.D., a professor of neurosurgery at Cardiff University in Wales in the United Kingdom, decided to conduct research to better understand the situation and perhaps find a way to remedy these patients’ learning deficits.
First Gray and his colleagues tested 12 mesial temporal lobe epilepsy subjects and 12 healthy control subjects to see how good their learning and memory capabilities were and found that the former group had more learning problems.
They then turned to a rat model for epilepsy and tested rats with this condition for learning and memory abilities. Compared with healthy rats, the rats with the epilepsy-like condition showed evidence of learning and memory deficits, just as the human subjects had.
Further testing suggested that the rats’ learning and memory impairments were due to reduced and abnormal production of new nerves in the hippocampus.
The scientists then gave fluoxetine to the epilepsy rats to see whether it might improve their learning and memory, since fluoxetine is known to improve memory in people with mild cognitive impairment and those with memory difficulties due to chemotherapy, or what is sometimes called “chemo brain” or “chemo fog” (Psychiatric News, March 16).
Fluoxetine did improve learning and hippocampal nerve regeneration in the study rats, but did not show any effect on memory improvement.
Thus fluoxetine might prove useful for improving learning in people with mesial temporal lobe epilepsy, Gray and his colleagues concluded in a report in the August Brain. “A well-tolerated pharmacological therapy that restores learning to normal could be of great clinical benefit,” they wrote.
They also remain hopeful that fluoxetine might help the memories of these epilepsy patients, at least in those with less-severe hippocampal damage, even though their animal tests did not point to this possibility.
The research was funded by Epilepsy Research UK.
An abstract of “Fluoxetine Restores Spatial Learning but Not Accelerated Forgetting in Mesial Temporal Lobe Epilepsy” is posted at http://brain.oxfordjournals.org/content/135/8/2358.abstract. >

Information & Authors

Information

Published In

Go to Psychiatric News
Psychiatric News
Volume 47 • Number 18 • September 21, 2012
Pages: 15b

History

Published online: 21 September 2012
Published in print: September 21, 2012

Authors

Details

Metrics & Citations

Metrics

Citations

Export Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Simply select your manager software from the list below and click Download.

For more information or tips please see 'Downloading to a citation manager' in the Help menu.

Format
Citation style
Style
Copy to clipboard
Tips for downloading citations

View Options

View options

Login options

Already a subscriber? Access your subscription through your login credentials or your institution for full access to this article.

Personal login Institutional Login Open Athens login

Not a subscriber?

Subscribe Now / Learn More

PsychiatryOnline subscription options offer access to the DSM-5-TR® library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.

Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).

Media

Figures

Other

Tables

Share

Share

Share article link

Share

×

As described within the American Psychiatric Association (APA)'s Privacy Policy and Terms of Use, this website utilizes cookies, including for the purpose of offering an optimal online experience and services tailored to your preferences. Please read the entire Privacy Policy and Terms of Use. By closing this message, browsing this website, continuing the navigation, or otherwise continuing to use the APA's websites, you confirm that you understand and accept the terms of the Privacy Policy and Terms of Use, including the utilization of cookies.